SynthesisIndian pediatrics2026
Comparison of Molecular Methods With Culture for Identifying Microbial Etiology in Pediatric Empyema Thoracis: A Systematic Review of Diagnostic Test Accuracy.
Synthesis in Indian pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 11 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 11 syntheses or guidelines pooled it.
- Predictors of Failure of Medical Management in Children with Empyema Thoracis: A Systematic Review.Indian pediatrics · 2026Pooled it
- Thoracic Computed Tomography Scan Versus Thoracic Ultrasonography for Management Decisions in Empyema Thoracis: A Systematic Review.Indian pediatrics · 2026Pooled it
- Thoracic Computed Tomography Scan Versus Thoracic Ultrasonography for Management Decisions in Empyema Thoracis: A Systematic Review.Indian pediatrics · 2026Pooled it
- Intrapleural Fibrinolytic Therapy as the Initial Modality, Compared to no Intrapleural Fibrinolytic Therapy, in Children With Empyema: A Systematic Review and Meta-analysis.Indian pediatrics · 2026Pooled it
- Intrapleural Fibrinolytic Therapy as the Initial Modality, Compared to no Intrapleural Fibrinolytic Therapy, in Children With Empyema: A Systematic Review and Meta-analysis.Indian pediatrics · 2026Pooled it
- Early Versus Late(r) Administration of Intrapleural Fibrinolytic Therapy in Children with Empyema: A Systematic Review and Meta-Analysis.Indian pediatrics · 2026Pooled it
- Early Versus Late(r) Administration of Intrapleural Fibrinolytic Therapy in Children with Empyema: A Systematic Review and Meta-Analysis.Indian pediatrics · 2026Pooled it
- Efficacy, Safety, and Long-Term Outcomes of Shorter (≤ 4 Weeks) Versus Longer (> 4 Weeks) Antibiotic Therapy in Pediatric Empyema Thoracis: A Systematic Review.Indian pediatrics · 2026Pooled it
- Efficacy, Safety, and Long-Term Outcomes of Shorter (≤ 4 Weeks) Versus Longer (> 4 Weeks) Antibiotic Therapy in Pediatric Empyema Thoracis: A Systematic Review.Indian pediatrics · 2026Pooled it
- Efficacy, Safety, and Long-Term Outcomes of Shorter (≤ 4 Weeks) Versus Longer (> 4 Weeks) Antibiotic Therapy in Pediatric Empyema Thoracis: A Systematic Review.Indian pediatrics · 2026Pooled it
- Empirical Antibiotic Therapy for the Management of Empyema Thoracis in Children: A Systematic Review.Indian pediatrics · 2026Pooled it
- Methodology Adopted for the Development of Evidence-Based Guideline Recommendations on Childhood Empyema.Indian pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
contextDetermining the microbial etiology in children with empyema thoracis can guide optimal treatment of individual children, and rational antimicrobial use in institutions. Culture methods and molecular diagnostic technologies are available, but there is no evidence-based guideline addressing the optimal diagnostic technology.
objectiveThis systematic review was undertaken to compare molecular diagnostic methods with culture methods for determining microbial etiology in children with empyema. EVIDENCE ACQUISITION: Literature search was undertaken in seven databases and four clinical trial registries, to identify diagnostic test accuracy (DTA) studies or diagnostic randomized controlled trials, comparing molecular methods with culture, for establishing the microbiological etiology of empyema. The outcomes were diagnostic accuracy parameters. Risk-of-bias and certainty of evidence were evaluated using the GRADE approach.
resultsNine DTA studies were included, however data from eight could be pooled. The pooled sensitivity of polymerase chain reaction (PCR) in pleural fluid specimens was 0.98 (95% CrI 0.91-0.99), and specificity 0.49 (95% CrI 0.19-0.75). The likelihood ratio of a positive result (LR+) was 1.90 (95% CrI 1.20-3.88), whereas LR- was 0.05 (95% CrI 0.01-0.23). Positive predictive value ranged from 0.11 to 1.0, and negative predictive value from 0.90 to 1.0. The diagnostic odds ratio was 38.23 (95% CrI 5.66-231.81). The overall risk of bias and overall applicability concerns were low in 3/8 studies and unclear in 5/8. The certainty of evidence was very low.
conclusionPleural fluid PCR has high sensitivity compared to culture, but moderate specificity. The optimal choice needs considerations beyond the comparative diagnostic accuracy.
Indexed as
Identifiers
42825895What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.